A recent study showed that silencing Pnpla3 with antisense oligonucleotides improved liver steatosis and fibrosis in Pnpla3 I148M knock-in mice, indicating that PNPAL3 could be a potential target for treatment in human (81). This evidence concerns the gene PNPLA3 and fatty liver disease.